Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions.
J. Krystal, A. Bennett, D. Abi‐Saab, Ayşenil Belger, L. Karper, D. D'Souza, D. Lipschitz, Anissa Abi‐dargham, D. Charney
Biological Psychiatry January 15, 2000 DOI: 10.1016/s0006-3223(99)00097-9 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental study with a placebo-controlled crossover component Peer reviewed |
|---|---|
| Sample size | 37 |
| Population | Healthy adult subjects |
| Intervention | Ketamine |
| Dose | intravenous bolus 0.26 mg/kg followed by infusion of 0.65 mg/kg/hour |
| Duration | Two test days spaced by approximately 1 week; first study two occasions separated by 1 week |
| Measures | Wisconsin Card Sorting Test (WCST) |
| Topics | Esketamine Ketamine |
| Key findings | A single WCST repetition reduced total and perseverative errors in healthy subjects, showing practice effects. Ketamine increased total errors, perseverative errors, and reduced categories met only on the first test day, not the second, while also causing psychosis, perceptual changes, distractibility, impaired recall, and negative-symptom-like effects. The authors contend that this order dependency implicates NMDA receptors in executive cognitive functions of the frontal cortex. |
Abstract
Background: The demands of the Wisconsin Card Sorting Test (WCST) change with experience. This report contains two studies designed to examine N-methyl-D-aspartate (NMDA) receptor contributions to the executive components of WCST performance. These aspects of WCST performance figure more prominently in the initial completion of this task than in subsequent task repetitions in healthy populations.
Methods: In the first study, healthy subjects (n = 15) completed the WCST on two occasions separated by 1 week. In the second study, healthy subjects (n = 22) completed two test days spaced by approximately 1 week, during which, they completed the WCST and other assessments after administration of the NMDA antagonist ketamine (intravenous bolus 0.26 mg/kg followed by infusion of 0.65 mg/kg/hour) or matched placebo.
Results: In the first study, subjects reduced the number of total and perseverative errors with a single repetition of the WCST. In the second study, ketamine significantly increased the number of total errors and the number and percent of perseverative errors on the first, but not the second test day. Similarly, it reduced the number of category criteria met on the first, but not second test day. Ketamine also increased distractibility, impaired recall, produced psychosis, altered perception, and had effects resembling the negative symptoms of schizophrenia. However, only WCST performance showed order dependency.
Conclusions: This order dependency further implicates NMDA receptors in executive cognitive functions associated with the frontal cortex.
Comparable studies
Other randomized controlled trials on ketamine, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Healthy human subjects recruited from the community | 1994 | Randomized controlled trial | n = 19 |
| Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial Patients with treatment-resistant major depression experiencing a major depressive episode | 2013 | Randomized controlled trial | n = 73 |
| Remifentanil-induced Postoperative Hyperalgesia and Its Prevention with Small-dose Ketamine Patients undergoing major abdominal surgery | 2005 | Randomized controlled trial | n = 75 |
| Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder Patients with chronic PTSD related to a range of trauma exposures | 2014 | Randomized controlled trial | n = 41 |
| Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers Healthy volunteers | 2000 | Single-blind placebo-controlled study | n = 20 |
Citations in the library
Cited by 22
- Brain mechanisms of hallucinogens and entactogens Dialogues in Clinical Neuroscience December 31, 2001
- A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics Trends in Neurosciences December 21, 2020
- Prevalence of new psychoactive substances and prescription drugs in the Belgian driving under the influence of drugs population Drug Testing and Analysis June 22, 2017
- Ketamine Psychedelic Psychotherapy: Focus on its Pharmacology, Phenomenology, and Clinical Applications International Journal of Transpersonal Studies July 1, 2014
- The thalamus in psychosis spectrum disorder. Frontiers in Neuroscience 2023
and 17 more in the library
Cites 7
- Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Archives of General Psychiatry March 1, 1994
- Recent advances in the phencyclidine model of schizophrenia American Journal of Psychiatry October 1, 1991
- The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate British Journal of Pharmacology June 1, 1983
- Measurement of dissociative states with the Clinician‐Administered Dissociative States Scale (CADSS) Journal of Traumatic Stress 1998
- Ketamine activates psychosis and alters limbic blood flow in schizophrenia Neuroreport April 1, 1995
and 2 more in the library